Thermo Fisher Scientific Inc.TMONYSE
LOADING
|||
Operating Income Performance
Above historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$7.66B
↑ 31% above average
Average (9y)
$5.86B
Historical baseline
Range
High:$10.32B
Low:$2.49B
CAGR
+13.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $7.66B | +2.9% |
| 2023 | $7.45B | -12.7% |
| 2022 | $8.53B | -17.4% |
| 2021 | $10.32B | +30.7% |
| 2020 | $7.90B | +85.4% |
| 2019 | $4.26B | +10.0% |
| 2018 | $3.87B | +18.5% |
| 2017 | $3.27B | +14.3% |
| 2016 | $2.86B | +14.6% |
| 2015 | $2.49B | - |